» Articles » PMID: 7444850

Binding of Platelet Factor 4 to Cultured Human Umbilical Vein Endothelial Cells

Overview
Journal Thromb Res
Date 1980 Jul 1
PMID 7444850
Citations 21
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prothrombotic Phenotype in COVID-19: Focus on Platelets.

Barale C, Melchionda E, Morotti A, Russo I Int J Mol Sci. 2021; 22(24).

PMID: 34948438 PMC: 8705811. DOI: 10.3390/ijms222413638.


TEG, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy.

Laubscher G, Lourens P, Venter C, Kell D, Pretorius E J Clin Med. 2021; 10(22).

PMID: 34830660 PMC: 8621180. DOI: 10.3390/jcm10225381.


Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.

Padmanabhan A, Jones C, Bougie D, Curtis B, McFarland J, Wang D Blood. 2014; 125(1):155-61.

PMID: 25342714 PMC: 4281824. DOI: 10.1182/blood-2014-06-580894.


Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia.

Sachais B, Rux A, Cines D, Yarovoi S, Garner L, Watson S Blood. 2012; 119(25):5955-62.

PMID: 22452981 PMC: 3383011. DOI: 10.1182/blood-2012-01-406801.


The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.

Bauer R, Der K, Barrientos J, Kung A Pharm Res. 1997; 14(2):224-9.

PMID: 9090714 DOI: 10.1023/a:1012013113759.